BridgeMD
New treatment option for Fear of Falling
Official title Fear of Falling in Muscular Dystrophy
ClinicalTrials.gov ID: NCT07129954
What this study is testing
- What it's testing
- Primary objectives WP1: Evaluate the prevalence of FOF in the study population and how this varies over time. Evaluate whether there are relationships between the variables investigated (clinical, motor, cognitive, psychological) and the presence of FOF.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 65
You may be able to join if
- Diagnosis of muscular dystrophy: myotonic, facio-scapular-humeral, Becker, cingulate, Emery-Dreifuss, and distal;
- 16 to 65 years of age;
- Patients with residual walking capacity: functional ambulation category (FAC) at least equal to 1
- MMSE corrected for age and education of 23,8 points. Specific Work Package 2 (WP2) inclusion criterion: \- the persistence of Fear Of Falling at 3...
You likely can't join if
- The presence of factors that may lead to the assumption that it is a priori impossible to ensure adequate adherence to the proposed treatment;
- Concurrent management in other rehabilitation centers or participation in other research projects
- Language barrier;
- Failure to sign informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Verona, verona, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Verona, verona, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.